3,5,3′triiodo-L-thyronine induces SREBP-1 expression by non-genomic actions in human HEP G2 cells

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2388-2397

  Gnoni, Gabriele V ^a   Rochira, Alessio ^a   Leone, Antonella ^b   Damiano, Fabrizio ^a   Marsigliante, Santo ^a   Siculella, Luisa ^a  

^a UNIVERSITY OF SALENTO   (Italy)

^b INSTITUTE OF SCIENCES OF FOOD PRODUCTION   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; AGAROSE; LIOTHYRONINE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN KINASE C ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TETRACAINE; VITRONECTIN RECEPTOR;

ARTICLE; CELL STRAIN HEPG2; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CARCINOMA, HEPATOCELLULAR; FEEDBACK, PHYSIOLOGICAL; HEP G2 CELLS; HUMANS; INTEGRIN ALPHAVBETA3; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; PROTEIN KINASE INHIBITORS; PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TIME FACTORS; TRIIODOTHYRONINE; UP-REGULATION;

EID: 84857483782     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22974     Document Type: Article

References (60)

1. Arnaout MA, Goodman SL, Xiong JP. 2002. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol 14: 641-651.
2. Bassett JH, Harvey CB, Williams GR. 2003. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213: 1-11.
3. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. 2005. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146: 2864-2871.
4. Blennemann B, Moon YK, Freake HC. 1992. Tissue-specific regulation of fatty acid synthesis by thyroid hormone. Endocrinology 130: 637-643.
5. Brown MS, Goldstein JL. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
6. Cao X, Kambe F, Moeller LC, Refetoff S, Seo H. 2005. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19: 102-112.
7. Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, Papa A, Nardella C, Cantley LC, Baselga J, Pandolfi PP. 2008. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest 118: 3065-3074.
8. Damiano F, Alemanno S, Gnoni GV, Siculella L. 2010. Translational control of the sterol-regulatory transcription factor SREBP-1 mRNA in response to serum starvation or ER stress is mediated by an internal ribosome entry site. Biochem J 429: 603-612.
9. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ. 2004. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 94: 1500-1506.
10. Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ, Lin HY. 2006. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 66: 7270-7275.
11. Davis PJ, Davis FB. 2002. Nongenomic actions of thyroid hormone on the heart. Thyroid 12: 459-466.
12. Davis PJ, Leonard JL, Davis FB. 2008. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol 29: 211-218.
13. Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB. 2000. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275: 38032-38039.
14. de Lange P, Senese R, Cioffi F, Moreno M, Lombardi A, Silvestri E, Goglia F, Lanni A. 2008. Rapid activation by 3, 5, 3′-L-triiodothyronine of adenosine 5′-monophosphate-activated protein kinase/acetyl-coenzyme a carboxylase and akt/protein kinase B signaling pathways: Relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo. Endocrinology 149: 6462-6470.
15. Du X, Kristiana I, Wong J, Brown AJ. 2006. Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: A link between a key cell proliferative pathway and membrane synthesis. Mol Biol Cell 17: 2735-2745.
16. Feng X, Jiang Y, Meltzer P, Yen PM. 2000. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol 14: 947-955.
17. Furuya F, Lu C, Guigon CJ, Cheng SY. 2009. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids 74: 628-634.
18. Giudetti AM, Leo M, Geelen MJ, Gnoni GV. 2005. Short-term stimulation of lipogenesis by 3, 5-L-diiodothyronine in cultured rat hepatocytes. Endocrinology 146: 3959-3966.
19. Giudetti AM, Leo M, Siculella L, Gnoni GV. 2006. Hypothyroidism down-regulates mitochondrial citrate carrier activity and expression in rat liver. Biochim Biophys Acta 1761: 484-491.
20. Gnoni GV, Geelen MJ, Bijleveld C, Quagliariello E, van den Bergh SG. 1985. Short-term stimulation of lipogenesis by triiodothyronine in maintenance cultures of rat hepatocytes. Biochem Biophys Res Commun 128: 525-530.
21. Gnoni GV, Landriscina C, Quagliariello E. 1980. Thyroid hormone stimulation of lipogenesis in isolated rat hepatocytes. Biochem Med 24: 336-347.
22. Grasselli E, Voci A, Canesi L, De Matteis R, Goglia F, Cioffi F, Fugassa E, Gallo G, Vergani L. 2011. Direct effects of iodothyronines on excess fat storage in rat hepatocytes. J Hepatol 54: 1230-1236.
23. Hashimoto K, Yamada M, Matsumoto S, Monden T, Satoh T, Mori M. 2006. Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. Endocrinology 147: 4292-4302.
24. Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
25. Kampfer S, Windegger M, Hochholdinger F, Schwaiger W, Pestell RG, Baier G, Grunicke HH, Uberall F. 2001. Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras. J Biol Chem 276: 42834-42842.
26. Kavok NS, Krasilnikova OA, Babenko NA. 2001. Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. BMC Cell Biol 2: 5.
27. Kawai K, Sasaki S, Morita H, Ito T, Suzuki S, Misawa H, Nakamura H. 2004. Unliganded thyroid hormone receptor-beta1 represses liver X receptor alpha/oxysterol-dependent transactivation. Endocrinology 145: 5515-5524.
28. Kenessey A, Ojamaa K. 2006. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281: 20666-20672.
29. Kochhar S, Hunziker PE, Leong-Morgenthaler P, Hottinger H. 1992. Primary structure, physicochemical properties, and chemical modification of NAD(+)-dependent D-lactate dehydrogenase. Evidence for the presence of Arg-235, His-303, Tyr-101, and Trp-19 at or near the active site. J Biol Chem 267: 8499-8513.
30. Kotzka J, Müller-Wieland D, Roth G, Kremer L, Munck M, Schürmann S, Knebel B, Krone W. 2000. Sterol regulatory element binding proteins (SREBP)-1a and SREBP-2 are linked to the MAP-kinase cascade. J Lipid Res 41: 99-108.
31. Krasilnikova OA, Kavok NS, Babenko NA. 2002. Drug-induced and postnatal hypothyroidism impairs the accumulation of diacylglycerol in liver and liver cell plasma membranes. BMC Physiol 2: 12.
32. Lanni A, Moreno M, Lombardi A, de Lange P, Goglia F. 2001. Control of energy metabolism by iodothyronines. J Endocrinol Invest 24: 897-913.
33. Lei J, Nowbar S, Mariash CN, Ingbar DH. 2003. Thyroid hormone stimulates Na-K-ATPase activity and its plasma membrane insertion in rat alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 285: L762-L772.
34. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ. 1999. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol 276: C1014-C1024.
35. Mariash CN, Oppenheimer JH. 1983. Interrelationship of triiodothyronine concentration, metabolism, protein binding, and nuclear occupancy in the induction of malic enzyme by cultured adult rat hepatocytes. Endocrinology 112: 80-85.
36. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D, Schächtele C. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 268: 9194-9197.
37. Mollica MP, Lionetti L, Moreno M, Lombardi A, de Lange P, Antonelli A, Lanni A, Cavaliere G, Barletta A, Goglia F. 2009. 3, 5-Diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet. J Hepatol 51: 363-370.
38. Muscella A, Urso L, Calabriso N, Vetrugno C, Rochira A, Storelli C, Marsigliante S. 2009. Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells. Br J Pharmacol 156: 751-763.
39. Nørby JG. 1988. Coupled assay of Na+, K+-ATPase activity. Methods Enzymol 156: 116-119.
40. O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, Baselga J, Rosen N. 2006. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 66: 1500-1508.
41. Pantos C, Xinaris C, Mourouzis I, Malliopoulou V, Kardami E, Cokkinos DV. 2006. Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: Potential therapeutic implications in reversing cardiac remodeling? Mol Cell Biochem 297: 65-72.
42. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. 2000. Ligand binding to integrins. J Biol Chem 275: 21785-21788.
43. Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J, Schulze A. 2005. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24: 6465-6481.
44. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, Griffiths JR, Chung YL, Schulze A. 2008. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8: 224-236.
45. 3 genomic and nongenomic actions. Am J Physiol Endocrinol Metab 295: E884-E894.
46. Roth G, Kotzka J, Kremer L, Lehr S, Lohaus C, Meyer HE, Krone W, Müller-Wieland D. 2000. MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. J Biol Chem 275: 33302-33307.
47. Scapin S, Leoni S, Spagnuolo S, Fiore AM, Incerpi S. 2008. Short-term effects of thyroid hormones on Na+-K+-ATPase activity of chick embryo hepatocytes during development: Focus on signal transduction. Am J Physiol Cell Physiol 296: C4-12.
48. Siculella L, Sabetta S, Giudetti AM, Gnoni GV. 2006. Hypothyroidism reduces tricarboxylate carrier activity and expression in rat liver mitochondria by reducing nuclear transcription rate and splicing efficiency. J Biol Chem 281: 19072-19080.
49. Silvestri E, Moreno M, Schiavo L, de Lange P, Lombardi A, Chambery A, Parente A, Lanni A, Goglia F. 2006. A proteomics approach to identify protein expression changes in rat liver following administration of 3, 5, 3′-triiodo-L-thyronine. J Proteome Res 5: 2317-2327.
50. Soh JW, Weinstein IB. 2003. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem 278: 34709-34716.
51. Tsai JH, Hsieh YS, Kuo SJ, Chen ST, Yu SY, Huang CY, Chang AC, Wang YW, Tsai MT, Liu JY. 2000. Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma. Cancer Lett 161: 171-175.
52. 3 action on Akt pathway in human pancreatic insulinoma cells. J Cell Biochem 106: 835-848.
53. 3 in pancreatic beta cells. J Mol Endocrinol 38: 221-233.
54. Viguerie N, Millet L, Avizou S, Vidal H, Larrouy D, Langin D. 2002. Regulation of human adipocyte gene expression by thyroid hormone. J Clin Endocrinol Metab 87: 630-634.
55. Wilson EJ, McMurray WC. 1981. Regulation of malic enzyme and mitochondrial alpha-glycerophosphate dehydrogenase by thyroid hormones, insulin, and glucocorticoids in cultured hepatocytes. J Biol Chem 256: 11657-11662.
56. Worgall TS, Johnson RA, Seo T, Gierens H, Deckelbaum RJ. 2002. Unsaturated fatty acid-mediated decreases in sterol regulatory element-mediated gene transcription are linked to cellular sphingolipid metabolism. J Biol Chem 277: 3878-3885.
57. Wu TT, Hsieh YH, Hsieh YS, Liu JY. 2008. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J Cell Biochem 103: 9-20.
58. Yang T, Goldstein JL, Brown MS. 2000. Overexpression of membrane domain of SCAP prevents sterols from inhibiting SCAP. SREBP exit from endoplasmic reticulum. J Biol Chem 275: 29881-29886.
59. Yen PM. 2001. Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142.
60. Zhang Y, Yin L, Hillgartner FB. 2003. SREBP-1 integrates the actions of thyroid hormone, insulin, cAMP, and medium-chain fatty acids on ACCalpha transcription in hepatocytes. J Lipid Res 44: 356-368.